adi-001
adicet bio
[' adi-001', 'adi-001 ', '$acet']
$acet reports emerging data from adi-001 phase 1 trial at #asco22 adi-001 demonstrated 75% cr and orr rate across all dose levels with favorable safety and tolerability profile.
80% orr and cr rate at dose levels 2 and 3 combined. 
Investor/trader focused primarily in the biopharma sector. 
Tweets are not investment advice and are not recommendations of any kind. @BTGPremium